IMNA Solutions, founded in 2014, is a software development company that has created a patented, highly secured data collection and patient management platform that is disorder agnostic. Our purpose-driven team of renowned doctors, medical professionals, security specialists, and data scientists take a patient-centric approach to managing medical conditions for healthcare providers and patients who are seeking to improve quality and level of care while reducing administrative tasks and costs.
For pharmaceutical companies and researchers
IMNA helps improve the process of data collection and reduces participant’s abandonment rate in clinical trials by providing an accurate electronic Patient Reported Outcomes assessment process. IMNA collects, extracts and analyzes patient healthcare information from multiple sources, turning unstructured data into real-time, actionable insights to better understand treatment options. Our proprietary platform uses patented data collection and clinical contextual ontology algorithms. The web-based visual database leverages predictive analytics, machine learning technology, and advanced natural language processing to help doctors quickly analyze and summarize patient information.
For clinical providers
IMNA follows patients and clinical trial participants 360 degrees throughout their medical lifecycle, facilitating personalized, high-quality patient care while increasing operational efficiency. By enabling the use of eVisits and electronic communications, IMNA ensures continuous monitoring, minimizes the gaps in patient relations and increases retention. To protect patient data, IMNA’s HIPPA and GDPR compliant platform uses military grade security with encrypted transmission and a highly secure vault storage for images.
Israel Haikin is the founder and CEO of IMNA Solutions. Israel founded IMNA Solutions in 2014 following a full career in government service including the Israel Security Agency where he worked extensively with the underlying technology that IMNA Solutions brings to market. As CEO, he is responsible for managing the overall operations and resources of the company. Throughout his 25-year career, Israel has led and inspired diverse, cross-cultural and cross-functional teams comprised of medical professionals, software engineers, data analysts, intelligence professionals, security professionals, and audio analysis technicians. Israel serves as chairman of the board of a privately-held international trading firm and a member of the Jewish Funders Network (JFN). He holds a master’s degree in business administration and management and a bachelor’s degree in political science and government from Bar-Ilan University.
Meirav Naor Weinstock is the chief business development officer and chief marketing officer of IMNA Solutions. She positions the company favorably with prospects and influencers in the healthcare community and provides critical feedback to the IMNA development team to refine the company’s product offerings. Meirav (May) brings decades of experience in international marketing, brand management and public relations to her position. She is a founding member of the Multiple Myeloma Research Lab that was established in 2009 to support new treatments of multiple myeloma. Meirav sits on the boards of Or Yarok, the Ran Naor Foundation for the Advancement of Road Safety and Research and is a member of the Jewish Funders Network (JFN). She holds a bachelor’s degree in business corporate communications and economics and an associate’s degree in international marketing from Hawaii Pacific University, and an associate’s degree in food and arts photography from Gavera School of Photography.
Dani Abitbol is the chief technology officer and vice president of R&D of IMNA Solutions. Beyond his technical capabilities, Dan’s true value is in his ability to conceive, design and build the technical solution necessary to achieve the non-technical vision of the founders. His ability to build and manage high-performing teams makes him a tremendous asset for IMNA. Throughout his career, Dan has demonstrated expertise developing solutions for Cloud (AWS, Google), Mobile (Android, iOS), Network, Databases, Servers, Clustering & auto-scaling, Multi-Threading, and Open Source. Dan holds a bachelor’s degree in computer science and mathematics and a mobile network architecture certification from Bar-Ilan University.
Yaron has over 25 years of experience in leading large-scale projects from early stages through implementation to completion. Prior to joining ISPAL in 2017, Yaron worked as a high-level negotiation and management liaison for an intelligence organization specializing in the middle east sector. Yaron holds a bachelor’s degree in near and middle eastern studies from Bar-Ilan University and a Master of Business Administration from Ono Academic College. He is fluent in Arabic, English, and Hebrew.
Professor Naim Shehadeh is a graduate of the Rappaport Faculty of Medicine at the Technion – Israel Institute of Technology in Haifa. Professor Shehadeh act as the head of Diabetes at Rambam hospital and chairman of the Israeli Diabetes Organization. He obtained his clinical training in Pediatrics and Endocrinology at Rambam Medical Center in Haifa and at the University of Colorado Health Sciences Center.He is Director of Pediatrics A and the Pediatric Diabetes Unit at Meyer Children’s Hospital of Haifa at Rambam Medical Center. Professor Shehadeh’s main research and clinical interests are pathogenesis and prevention of Type 1 Diabetes and the effect of oral insulin on the gastrointestinal tract. Professor Shehadeh has received a number of research and innovation awards including the Hershel Rich Technion Innovation Award and the Raymond and Miriam Klein Technion Research Award.
Mr. Zur Ezion provides Legal Business Consulting and has extensive experience in cross-border mergers and acquisitions as well as finance and investments transactions. Mr. Zur works with multinational companies and with large private companies and investors operating in a number of sectors.
Professor Itzhak Avital MD, MBA, FACS is a surgical oncologist and Chairman of the Department of Surgery at Saint Peter’s University Hospital and Soroka Hospital. Professor Avital is the Executive Medical Director of The Bon Secours Cancer Institute in Virginia and the new oncology ME center in Soroka hospital, which are dedicated to studying and applying the latest evidence-based treatments for cancer.
Mr. Naor is the founder and Chairman of Or-Yarok Association and the Chairman of the National Authority for Highway Safety Steering Committee. Prior to this Mr. Naor served as President & CEO of Amdocs (NYSE: DOX), a global leader in billing systems, CRM, self-service, order management, mediation, and content revenue management. Mr. Naor was also a member of the Aurec Group, an Israeli-based private equity firm with cable and telecom investments.
Vice President Marketing
VP Innovations North America
Server-Side Team Leader
Algorithm Software Engineer
Android Software Developer
Senior Software Developer
UI / UX Architect & Designer